ABSTRACT
Influenza virus infection causes worldwide seasonal epidemics. Although influenza is usually a mild disease, a minority of patients experience very severe fulminating disease courses. Previous studies have demonstrated a role for type I interferon (IFN) in anti-viral responses during influenza. So far, however, IFN regulatory factor (IRF)7 deficiency is the only genetic cause of severe influenza described in humans. In this study we present a patient with severe influenza A virus (IAV) H1N1 infection during the 2009 swine flu pandemic. By whole exome sequencing we identified two variants, p.R71H and p.P885S, located in the caspase activation and recruitment domain (CARD) and RNA binding domains, respectively, of DExD/H-box helicase 58 (DDX58) encoding the RNA sensor retinoic acid inducible gene 1 (RIG-I). These variants significantly impair the signalling activity of RIG-I. Similarly, patient cells demonstrate decreased antiviral responses to RIG-I ligands as well as increased proinflammatory responses to IAV, suggesting dysregulation of the innate immune response with increased immunopathology. We suggest that these RIG-I variants may have contributed to severe influenza in this patient and advocate that RIG-I variants should be sought in future studies of genetic factors influencing single-stranded RNA virus infections.
Subject(s)
DEAD Box Protein 58/genetics , Immunity, Innate/genetics , Immunity, Innate/immunology , Influenza A Virus, H1N1 Subtype/immunology , Influenza, Human/immunology , Adult , DEAD Box Protein 58/metabolism , Humans , Influenza, Human/pathology , Influenza, Human/virology , Male , Protein Domains/genetics , Receptors, Immunologic , Exome SequencingABSTRACT
Avian bornaviruses (ABV) have been discovered in 2008 as the causative agent of proventricular dilatation disease (PDD) in psittacine birds. To date, six ABV genotypes have been described in psittacines. Furthermore, two additional but genetically different ABV genotypes were recognized in non-psittacine birds such as canary birds and wild waterfowl. This remarkable genetic diversity poses a considerable challenge to ABV diagnosis, since polymerase chain reaction (PCR) assays may fail to detect distantly related or as yet unknown genotypes. In this study we investigated the use of virus isolation in cell culture as a strategy for improving ABV diagnosis. We found that the quail fibroblast cell line CEC-32 allows very efficient isolation of ABV from psittacine birds. Isolation of ABV was successful not only from organ samples but also from cloacal and pharyngeal swabs and blood samples collected intra vitam from naturally infected parrots. Importantly, using this experimental approach we managed to isolate a new ABV genotype, termed ABV-7, from a salmon-crested cockatoo (Cacatua moluccensis). Phylogenetic analysis showed that ABV-7 is most closely related to the psittacine genotypes ABV-1, -2, -3, and -4 and clearly distinct from genotypes ABV-5 and -6. Our successful identification of ABV-7 emphasizes the necessity to consider the high genetic diversity when trying to diagnose ABV infections with high reliability and further shows that classical virus isolation may represent a useful diagnostic option, particularly for the detection of new ABV genotypes.
Subject(s)
Bird Diseases/virology , Bornaviridae/genetics , Bornaviridae/isolation & purification , Cockatoos/virology , Mononegavirales Infections/veterinary , Psittaciformes/virology , Animals , Base Sequence , Bornaviridae/classification , Cell Line , Genes, Viral/genetics , Genotype , Molecular Sequence Data , Mononegavirales Infections/virology , Phylogeny , Sequence AlignmentABSTRACT
Mx proteins are interferon-induced large GTPases with antiviral activities. They inhibit a wide range of viruses by blocking early stages of the replication cycles. Importantly, Mx GTPases also suppress the growth of highly pathogenic influenza A viruses, such as currently circulating H5N1 viruses or the pandemic H1N1 virus strain of 1918. In this paper, the authors review the properties of Mx proteins and discuss their role in host defence against highly pathogenic viruses. The authors further suggest that mammalian Mx proteins may normally provide a barrier against zoonotic transmission of avian influenza A viruses and that acquired resistance to the antiviral action of human MxA may be one factor, among many others, that facilitates the spread of pandemic strains in human populations. The presently available evidence suggests that Mx proteins of domestic chickens lack the ability to efficiently combat avian influenza viruses known to cause devastating infections in this species. The deliberate introduction of an antivirally active Mx gene originating from resistant birds or mammals may confer some degree of protection and thus stop commercial birds from serving as amplifying hosts of potentially pandemic influenza virus strains.
Subject(s)
GTP Phosphohydrolases/immunology , GTP Phosphohydrolases/metabolism , Influenza A virus/immunology , Interferons/physiology , Animals , GTP Phosphohydrolases/classification , GTP Phosphohydrolases/genetics , Humans , Influenza A virus/pathogenicity , PhylogenyABSTRACT
Persistence of RNA viruses is frequently associated with non-uniform terminal nucleotide deletions at both ends of the viral genome, which are believed to restrict viral replication and transcription during persistent infection. Borna disease virus (BDV), a negative strand RNA virus with no recognizable acute phase, quickly establishes persistence. We recently demonstrated that the vast majority of BDV genomes and antigenomes possess uniformly trimmed 5' termini, even if the virus is recovered from complementary DNA encoding a hypothetical full-length viral genome. Here we discuss different mechanisms which might lead to the selective 5'-terminal trimming of the BDV genome and subsequent retrieval of the lost genetic information. We further discuss possible benefits of genome trimming in the light of recent findings that terminal RNA structures are recognized by intracellular sensors which trigger innate immunity. We hypothesize that 5'-terminal genome trimming might represent a smart strategy of BDV to evade the antiviral host response.
Subject(s)
Borna disease virus/genetics , Genome, Viral , Base Sequence , Borna Disease/genetics , Borna disease virus/physiology , Humans , RNA Viruses/genetics , RNA, Viral/genetics , Virus ReplicationSubject(s)
Borna disease virus/genetics , Central Nervous System Diseases/pathology , Epilepsy , RNA, Viral/analysis , Antibodies, Monoclonal/metabolism , Blotting, Southern , Epilepsy/pathology , Epilepsy/surgery , Hippocampus/metabolism , Hippocampus/pathology , Hippocampus/surgery , Humans , Immunohistochemistry , Nucleic Acid Amplification Techniques , Polymerase Chain Reaction , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, RNAABSTRACT
Borna disease virus (BDV) infection in its predominant natural host - horses and sheep - leads to fatal meningoencephalomyelitis. The immune-mediated disease can also be induced experimentally in rats following intra- cerebral BDV infection. Despite a vigorous immune response, BDV persists in the central nervous system (CNS) in surviving rats. However, immunization of rats with BDV-specific T-cells prior to challenge with BDV prevents neurological disease and results in virus clearance from the CNS. To analyze whether interferon gamma (IFNgamma) might contribute to viral clearance in the rat brain, we tested the susceptibility of BDV to the antiviral action of rat IFNgamma using different rat cell lines. Even at high concentrations of IFNgamma, BDV infection of astrocyte and fibroblast cell lines as well as of rat embryo cells could not be inhibited efficiently. Similarly, infection of cultured rat hippocampal slices with BDV was not inhibited by rat IFNgamma. In contrast, de novo BDV infection of monkey kidney cells as well as human oligodendroglial cells was blocked by preincubation with human IFNgamma. Furthermore, IFNgamma reduced the BDV load in persistently BDV-infected human oligodendroglial cells but not in infected rat astrocytes. These data suggest species-specific differences in the susceptibility of BDV to the antiviral action of IFNgamma.
Subject(s)
Antiviral Agents/pharmacology , Borna disease virus/drug effects , Interferon-gamma/pharmacology , Animals , Borna Disease/prevention & control , Cell Line , Female , Hippocampus/virology , Humans , Rats , Rats, Inbred Lew , Species Specificity , Virus Replication/drug effectsABSTRACT
Borna disease virus (BDV) polymerase can be reconstituted by co-expression of the viral genes N, P and L. N codes for two proteins, p39 and p38, resulting from alternative translation initiation. Using a viral minireplicon system we observed that unlike p39, p38 was almost completely inactive when expressed with P and L alone. Since BDV polymerase requires a 10-20 fold excess of N protein over P for high activity, we determined whether p38 might serve as buffer that influences the viral N:P ratio. We demonstrate that p38 efficiently rescued BDV polymerase activity in cells expressing unfavorably high amounts of P.
Subject(s)
Borna disease virus/enzymology , Nucleoproteins/genetics , Nucleoproteins/physiology , RNA-Dependent RNA Polymerase/metabolism , Viral Proteins/physiology , Borna disease virus/physiology , Codon, Initiator , Gene Expression Regulation, Viral , Genes, Viral , Protein Biosynthesis , Protein Isoforms/genetics , Protein Isoforms/physiology , RNA-Dependent RNA Polymerase/genetics , Replicon , Sequence Deletion , Viral Proteins/genetics , Virus ReplicationABSTRACT
Borna Disease (BD) is a mostly fatal disease of horses and sheep endemic in central Europe. Antibodies to Borna disease virus (BDV) have been described in sheep and other species living in BD non-endemic areas. Meaningful clinical BDV serology is hampered by difficulties in defining serological cut-offs, which require the investigation of populations from endemic areas. Here we studied BD serology in sheep from endemic and non-endemic areas of similar geography in Switzerland. Antibodies to BDV antigens were detected by ELISA and indirect immunofluorescence analysis (IFA) only in sera from 3 of 6 sheep with autopsy confirmed BD. One serum was positive by IFA but not by ELISA, while 2 sera were negative in both assays, indicating that not all diseased animals develop BDV specific antibodies. Six % of clinically healthy animals (6/106) from an endemic area and 2% from a non-endemic area (4/192) had serum antibody to either BDV p40 or p24 as detected by ELISA. None of the animals showed a cellular immune response to BDV p40. In some healthy sheep from the endemic area, serum antibody titers to BDV p24 antigen remained elevated over several months without onset of disease symptoms. Infections with either BDV or related viruses may thus occur at low frequency in sheep from non-endemic areas leading to the production of antibodies to BDV antigens. We further propose viral strain differences or environmental factor(s) may determine the clinical outcome.
Subject(s)
Antibodies, Viral/blood , Borna Disease/immunology , Borna disease virus/immunology , Sheep Diseases/immunology , Animals , Antibodies, Viral/biosynthesis , Borna Disease/epidemiology , Enzyme-Linked Immunosorbent Assay/veterinary , Fluorescent Antibody Technique, Indirect/veterinary , Hypersensitivity, Delayed/veterinary , Immunity, Cellular , Seroepidemiologic Studies , Sheep , Sheep Diseases/epidemiology , Sheep Diseases/virology , Switzerland/epidemiologyABSTRACT
Perforin-mediated lysis of target cells is the major antiviral effector mechanism of CD8(+) T lymphocytes. We have analyzed the role of perforin in a mouse model for CD8(+) T-cell-mediated central nervous system (CNS) immunopathology induced by Borna disease virus. When a defective perforin gene was introduced into the genetic background of the Borna disease-susceptible mouse strain MRL, the resulting perforin-deficient mice developed strong neurological disease in response to infection indistinguishable from that of their perforin-expressing littermates. The onset of disease was slightly delayed. Brains of diseased perforin-deficient mice showed similar amounts and a similar distribution of CD8(+) T cells as wild-type animals. Perforin deficiency had no impact on the kinetics of viral spread through the CNS. Unlike brain lymphocytes from diseased wild-type mice, lymphocytes from perforin-deficient MRL mice showed no in vitro cytolytic activity towards target cells expressing the nucleoprotein of Borna disease virus. Taken together, these results demonstrate that CD8(+) T cells mediate Borna disease independent of perforin. They further suggest that the pathogenic potential of CNS-infiltrating CD8(+) T cells does not primarily reside in their lytic activity but rather in other functions.
Subject(s)
Borna Disease/pathology , Brain/pathology , CD8-Positive T-Lymphocytes/physiology , Membrane Glycoproteins/physiology , Animals , Borna Disease/immunology , Borna Disease/virology , Brain/virology , CD4-Positive T-Lymphocytes/physiology , Mice , Mice, Inbred MRL lpr , Perforin , Pore Forming Cytotoxic ProteinsABSTRACT
Eight chicken cytokine genes (IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma, TGF-beta4, lymphotactin) were evaluated for their adjuvant effect on a suboptimal dose of an Eimeria DNA vaccine carrying the 3-1E parasite gene (pcDNA3-1E). Chickens were given two subcutaneous injections with 50 microg of the pcDNA3-1E vaccine plus a cytokine expression plasmid 2 weeks apart and challenged with Eimeria acervulina 1 week later. IFN-alpha (1 microg) or 10 microg of lymphotactin expressing plasmids, when given simultaneously with the pcDNA3-1E vaccine, significantly protected against body weight loss induced by E. acervulina. Parasite replication was significantly reduced in chickens given the pcDNA3-1E vaccine along with 10 microg of the IL-8, lymphotactin, IFN-gamma, IL-15, TGF-beta4, or IL-1beta plasmids compared with chickens given the pcDNA3-1E vaccine alone. Flow cytometric analysis of duodenum intraepithelial lymphocytes showed chickens that received the pcDNA3-1E vaccine simultaneously with the IL-8 or IL-15 genes had significantly increased CD3+ cells compared with vaccination using pcDNA3-1E alone or in combination with the other cytokine genes tested. These results indicate that the type and the dose of cytokine genes injected into chickens influence the quality of the local immune response to DNA vaccination against coccidiosis.
Subject(s)
Adjuvants, Immunologic , Coccidiosis/veterinary , Eimeria/immunology , Interferons/immunology , Interleukins/immunology , Lymphokines/immunology , Poultry Diseases/prevention & control , Sialoglycoproteins/immunology , Transforming Growth Factor beta/immunology , Animals , Chickens , Coccidiosis/immunology , Coccidiosis/prevention & control , Drug Evaluation, Preclinical , Duodenum/immunology , Duodenum/parasitology , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Interferon-alpha/genetics , Interferon-alpha/immunology , Interferon-gamma/genetics , Interferon-gamma/immunology , Interferons/genetics , Interleukin-1/genetics , Interleukin-1/immunology , Interleukin-15/genetics , Interleukin-15/immunology , Interleukin-2/genetics , Interleukin-2/immunology , Interleukin-8/genetics , Interleukin-8/immunology , Interleukins/genetics , Lymphokines/genetics , Parasite Egg Count , Poultry Diseases/immunology , Sialoglycoproteins/genetics , Specific Pathogen-Free Organisms , Transforming Growth Factor beta/genetics , Vaccination/veterinary , Vaccines, DNA/genetics , Vaccines, DNA/immunology , Weight GainABSTRACT
The effects of triiodothyronine (T3), thymulin, and recombinant chicken interferon-y (ChIFN-gamma) on natural killer (NK) cell cytotoxicity was investigated using the euthyroid control K and the T3-deficient sex-linked dwarf (SLD) chicken strains. Factorial design experiments were used to investigate the effects of T3 treatments where animals of both strains received either 0 or 0.1 ppm T3 supplementation to the standard chick starter diet. The ChIFN-gamma treatments were administered in vitro by incubation with effector cells overnight prior to the addition of the RP9 lymphoblastoma target cell line. All cytotoxicity assays were run at 50:1 and 25:1 effector/target (E/T) ratios. Treatments were begun at hatching and continued through 7 weeks. NK cells for these assays were enriched by separation of splenocytes over ficoll. Splenocyte preparations from untreated K strain consistently had significantly higher NK-mediated cytolysis than did samples from the untreated SLD at both E/T ratios. T3 treatment alone had no effect on NK activity in cell preparations from the K strain but did significantly enhance that activity in the T3-deficient SLD whereas IFN treatment alone enhanced NK activity in both strains. The combined T3 and IFN treatments resulted in a greater enhancement of NK cytolytic activity in both strains than any separate treatment and resulted in an elimination of differences in NK cell responsiveness between the K and SLD strains. Similar results were obtained when NK cell cultures were incubated in vitro with thymulin prior to assessing cytotoxicity. In vitro thymulin treatments alone significantly enhanced cytolytic activity for NK cells for both K and SLD strains. The greatest effect of in vitro thymulin exposure was to increase the responsiveness to NK cells to ChIFN-gamma stimulation.
Subject(s)
Cytotoxicity, Immunologic/drug effects , Killer Cells, Natural/drug effects , Thymic Factor, Circulating/pharmacology , Triiodothyronine/pharmacology , Animals , Cell Survival , Chickens , In Vitro Techniques , Interferon-gamma/pharmacology , Neurosecretory Systems/drug effects , Recombinant Proteins , Species Specificity , Tumor Cells, CulturedABSTRACT
Borna disease virus (BDV)-induced immunopathology in mice is most prominent in strains carrying the major histocompatibility complex H-2k allele and is mediated by CD8(+) T cells that are directed against the viral nucleoprotein p40. We now identified the highly conserved octamer peptide TELEISSI, located between amino acid residues 129 and 136 of BDV p40, as a potent H-2K(k)-restricted cytotoxic T-cell (CTL) epitope. When added to the culture medium of L929 target cells, TELEISSI conferred sensitivity to lysis by CTLs isolated from brains of BDV-infected MRL mice with acute neurological disease. Vaccinia virus-mediated expression of a p40 variant with mutations in the two K(k)-specific anchor residues of the TELEISSI peptide (p40(E130K,I136T)) did not sensitize L929 target cells for lysis by BDV-specific CTLs, whereas expression of wild-type p40 did. Furthermore, unlike vaccination with wild-type p40, vaccination of persistently infected symptomless B10.BR mice with p40(E130K,I136T) did not result in central nervous system inflammation and neurological disease. These results demonstrate that TELEISSI is the immunodominant CTL epitope of BDV p40 in H-2k mice.
Subject(s)
Borna disease virus/immunology , Epitopes, T-Lymphocyte/immunology , H-2 Antigens/immunology , Immunodominant Epitopes/immunology , Nucleoproteins/immunology , T-Lymphocytes, Cytotoxic/immunology , Viral Proteins/immunology , Animals , Borna disease virus/genetics , Cell Line , Chlorocebus aethiops , Electronic Data Processing , Epitope Mapping , Epitopes, T-Lymphocyte/genetics , Immunodominant Epitopes/genetics , Mice , Mice, Inbred MRL lpr , Mutagenesis , Nucleoproteins/genetics , Rats , Viral Proteins/geneticsABSTRACT
Suppression subtractive hybridization technology was used to identify differentially expressed genes in spleens of chickens that had been treated with the synthetic immune modifier S-28463. One induced chicken gene encoded a protein with about 35% sequence identity to human interleukin-6 (IL-6). It consists of 241 amino acids including a putative N-terminal signal peptide of 47 residues. Bacterially expressed chicken IL-6 (ChIL-6) carrying a histidine tag in place of the signal peptide was biologically active: it induced proliferation of the IL-6-dependent murine hybridoma cell line 7TD1. The concentration of ChIL-6 required for half-maximal proliferative response was approximately 60 pg.mL-1. When injected intravenously into adult chickens, purified recombinant ChIL-6 induced an increase in serum corticosterone levels. Supernatants of chicken LMH and monkey COS-7 cells transiently transfected with a ChIL-6 expression construct induced proliferation of 7TD1 cells, demonstrating that recombinant ChIL-6 from eukaryotic cells is also active.
Subject(s)
DNA, Complementary/chemistry , Interleukin-6/chemistry , Interleukin-6/physiology , Amino Acid Sequence , Aminoquinolines/pharmacology , Animals , Base Sequence , Blotting, Northern , COS Cells , Cell Division , Chickens , DNA, Complementary/metabolism , Dose-Response Relationship, Drug , Escherichia coli/metabolism , Gene Library , Histidine/chemistry , Humans , Interleukin-6/metabolism , Mice , Molecular Sequence Data , Nucleic Acid Hybridization , Poly A , Protein Sorting Signals , RNA, Messenger/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Spleen/metabolism , Time Factors , Transfection , Tumor Cells, CulturedABSTRACT
Borna disease virus (BDV) is a noncytolytic RNA virus that can replicate in the central nervous system (CNS) of mice. This study shows that BDV multiplication was efficiently blocked in transgenic mice that express mouse alpha-1 interferon (IFN-alpha1) in astrocytes. To investigate whether endogenous virus-induced IFN might similarly restrict BDV, we used IFNAR(0/0) mice, which lack a functional alpha/beta IFN (IFN-alpha/beta) receptor. As would be expected if virus-induced IFN were important to control BDV infection, we found that cultured embryo cells of IFNAR(0/0) mice supported viral multiplication, whereas cells from wild-type mice did not. Unexpectedly, however, BDV spread through the CNSs of IFNAR(0/0) and wild-type mice with similar kinetics, suggesting that activation of endogenous IFN-alpha/beta genes in BDV-infected brains was too weak or occurred too late to be effective. Surprisingly, Northern blot analysis showed that the levels of the most abundant viral mRNAs in the brains of persistently infected IFNAR(0/0) mice were about 20-fold lower than those in wild-type mice. In contrast, genomic viral RNA was produced in about a 10-fold excess in the brains of IFNAR(0/0) mice. Human IFN-alpha2 similarly enhanced transcription and simultaneously repressed replication of the BDV genome in persistently infected Vero cells. Thus, in persistently infected neurons and cultured cells, IFN-alpha/beta appears to freeze the BDV polymerase in the transcriptional mode, resulting in enhanced viral mRNA synthesis and suppressing viral genome replication.
Subject(s)
Borna Disease/virology , Borna disease virus/physiology , Interferon-alpha/physiology , Interferon-beta/physiology , Transcription, Genetic , Virus Replication , Animals , Astrocytes/immunology , Astrocytes/virology , Borna disease virus/genetics , Brain/virology , Cells, Cultured , Chlorocebus aethiops , Female , Genome, Viral , Interferon-alpha/genetics , Interferon-alpha/pharmacology , Interferon-beta/genetics , Male , Mice , Mice, Transgenic , RNA, Viral/analysis , Receptors, Interferon/genetics , Receptors, Interferon/metabolism , Transgenes , Vero CellsABSTRACT
Antibodies recognizing Borna disease virus (BDV) antigens were first demonstrated in the blood of psychiatric patients approximately 15 years ago. Since that time, a highly controversial debate arose whether BDV infects humans and whether it causes psychiatric disorders. In this review, we critically discuss the results of numerous studies that assessed this possibility by using virological and serological methods. We conclude that there is presently no strong experimental evidence supporting the notion that BDV is a human pathogen. The possibility remains, however, that an antigenically related agent is associated with human psychiatric disorders.
Subject(s)
Borna Disease , Borna disease virus/pathogenicity , Mental Disorders/virology , RNA Virus Infections , Amantadine/pharmacology , Amantadine/therapeutic use , Animals , Antibodies, Viral/blood , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Borna Disease/diagnosis , Borna Disease/drug therapy , Borna Disease/epidemiology , Borna Disease/virology , Borna disease virus/drug effects , Borna disease virus/immunology , Borna disease virus/isolation & purification , Brain/virology , Humans , Mental Disorders/drug therapy , RNA Virus Infections/diagnosis , RNA Virus Infections/drug therapy , RNA Virus Infections/epidemiology , RNA Virus Infections/virology , RNA, Viral/analysis , ViremiaABSTRACT
Borna disease virus (BDV) can induce neurological disease in animals. Since viral nucleic acid, infectious particles and antibodies recognizing BDV antigens were found at higher frequencies in psychiatric patients than in healthy controls, BDV is suspected to cause psychiatric disorders in humans. However, the human origin of these viruses has recently been questioned. To diagnose BDV infections, sera are usually analyzed for antiviral antibodies by indirect immunofluorescence (IFA) on virus-infected cells. This study reveals that the reactive antibodies in human sera mainly recognized the BDV phosphoprotein, whereas animal sera preferentially detected the viral nucleoprotein. Immunoglobulin (Ig) G in sera of experimentally or naturally infected animals bound to the viral antigen with high avidity, ie resisting 3 M urea, whereas reactive IgG in human sera did not. Longitudinal studies showed that reactive human antibodies persisted for many years without gaining high avidity for BDV antigens, indicating that they were probably not induced by BDV but rather by infection with an antigenically related microorganism of unknown identity or by exposure to other related immunogens.
Subject(s)
Antibodies, Viral/immunology , Borna Disease/diagnosis , Borna Disease/immunology , Borna disease virus/immunology , Animals , Antibody Affinity , Antigens, Viral/immunology , Chlorocebus aethiops , Fluorescent Antibody Technique, Indirect , Horses , Humans , Immunoglobulin G/immunology , Kidney/cytology , Mental Disorders/immunology , Mental Disorders/virology , Rats , Species Specificity , Vero CellsABSTRACT
Borna disease virus (BDV) is a highly neurotropic RNA virus that causes a CD8(+) T cell-mediated neurological disease in certain mouse strains. We established asymptomatic persistent central nervous system (CNS) infections in mutant C57BL/10J mice that lack functional CD8(+) T cells. When analyzed at adult age for spatial learning abilities in a water maze, BDV-infected mice showed slightly impaired escape performance while their exploratory behavior in an openfield test was indistinguishable from uninfected control mice. Histological and molecular biological analysis revealed extensive viral spread throughout the CNS of infected animals. Most neurons of the hippocampus contained viral antigen, but there was no overt loss of neurons from this structure. We found almost unchanged levels of the proinflammatory cytokines IL-1beta and TNF-alpha, but clearly increased levels of the chemokines IP-10 and RANTES in brains of infected mice. Re-examination of water maze data revealed that only infected mice with IP-10 transcript levels above a certain threshold showed impaired performance, whereas the performance of infected mice with lower IP-10 levels was indistinguishable from uninfected controls. This suggests that BDV infection can disturb the function of the mammalian CNS without causing overt neuronal loss, and that the magnitude of virus-induced chemokine production in the CNS correlates with the degree of impairment.
Subject(s)
Borna Disease/metabolism , Borna Disease/psychology , Borna disease virus , Central Nervous System Infections/metabolism , Central Nervous System Infections/psychology , Chemokines/biosynthesis , Learning Disabilities/psychology , Animals , Antineoplastic Agents/metabolism , Behavior, Animal/physiology , Biomarkers , Blotting, Northern , Borna Disease/complications , Chemokine CXCL10/biosynthesis , Exploratory Behavior/physiology , Immunohistochemistry , Learning Disabilities/etiology , Maze Learning/physiology , Memory/physiology , Mice , Mice, Inbred C57BL , RNA/biosynthesis , Ribonucleases/metabolism , Viral LoadABSTRACT
Targeted disruptions of the mouse genes for cytokines, cytokine receptors, or components of cytokine signaling cascades convincingly revealed the important roles of these molecules in immunologic processes. Cytokines are used at present as drugs to fight chronic microbial infections and cancer in humans, and they are being evaluated as immune response modifiers to improve vaccines. Until recently, only a few avian cytokines have been characterized, and potential applications thus have remained limited to mammals. Classic approaches to identify cytokine genes in birds proved difficult because sequence conservation is generally low. As new technology and high throughput sequencing became available, this situation changed quickly. We review here recent work that led to the identification of genes for the avian homologs of interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma, various interleukins (IL), and several chemokines. From the initial data on the biochemical properties of these molecules, a picture is emerging that shows that avian and mammalian cytokines may perform similar tasks, although their primary structures in most cases are remarkably different.
Subject(s)
Chickens/immunology , Cytokines/physiology , Adjuvants, Immunologic/pharmacology , Amino Acid Sequence , Animals , Birds/genetics , Birds/immunology , Chemokines/genetics , Chemokines/physiology , Chickens/genetics , Cytokines/genetics , Cytokines/pharmacology , Disease Models, Animal , Humans , Interferons/genetics , Interferons/physiology , Interleukins/genetics , Interleukins/physiology , Molecular Sequence Data , Sequence Homology, Amino Acid , Virus Diseases/immunologyABSTRACT
By searching a chicken EST database, we identified a cDNA clone that appeared to contain the entire open reading frame (ORF) of chicken interleukin-18 (ChIL-18). The encoded protein consists of 198 amino acids and exhibits approximately 30% sequence identity to IL-18 of humans and various others mammals. Sequence comparisons reveals a putative caspase-1 cleavage site at aspartic acid 29 of the primary translation product, indicating that mature ChIL-18 might consist of 169 amino acids. Bacterially expressed ChIL-18 in which the N-terminal 29 amino acids of the putative precursor molecule were replaced by a histidine tag induced the synthesis of interferon-gamma (IFN-gamma) in cultured primary chicken spleen cells, indicating that the recombinant protein is biologically active.